Direct oral anticoagulants for the treatment of cerebral venous thrombosis – a protocol of an international phase IV study
CORRECTION article
Corrigendum: Direct oral anticoagulants for the treatment of cerebral venous thrombosis – a protocol of an international phase IV study
Provisionally accepted- 1 Department of Neurology, Amsterdam University Medical Center, Amsterdam, Netherlands
- 2 Christian Medical College and Hospital, Vellore, Tamil Nadu, India
- 3 Lisbon Central Hospital Center, Lisbon, Portugal
- 4 Spitalul Universitar de Urgenţă Bucureşti, Bucharest, Romania
- 5 Manuel Velasco Suárez National Institute of Neurology and Neurosurgery, Mexico City, México, Mexico
- 6 Rafael Angel Calderon Guardia Hospital, San José, San Jose, Costa Rica
- 7 Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, São Paulo, Brazil
- 8 ASST Sette Laghi, Varese, Italy
- 9 Hospital Clínico de la Universidad de Chile, Santiago, Santiago Metropolitan Region (RM), Chile
- 10 Xuanwu Hospital, Capital Medical University, Beijing, Beijing Municipality, China
- 11 Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Västergötland, Sweden
- 12 Sahlgrenska University Hospital, Gothenburg, Sweden
- 13 Inselspital University Hospital Bern, Bern, Bern, Switzerland
- 14 Hospital Germans Trias i Pujol, Badalona, Spain
- 15 Duke University Hospital, Durham, North Carolina, United States
- 16 Royal Adelaide Hospital, Adelaide, South Australia, Australia
- 17 Akershus University Hospital, Lørenskog, Norway
- 18 Department of Neurology, Hadassah Medical Center, Jerusalem, Jerusalem, Israel
- 19 University Hospitals Leuven, Leuven, Brussels, Belgium
- 20 Tübingen University Hospital, Tübingen, Baden-Württemberg, Germany
- 21 Istanbul Tip Fakültesi, Istanbul, Germany
- 22 Aga Khan University, Karachi, Sindh, Pakistan
- 23 Christchurch Hospital, Christchurch, Canterbury, New Zealand
- 24 Centro Hospitalar Lisboa Norte (CHLN), Lisbon, Portugal
- 25 Radboud University Medical Centre, Nijmegen, Gelderland, Netherlands
- 26 Helsinki University Central Hospital, Helsinki, Uusimaa, Finland
- 27 Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden
- 28 Centro de Estudos Egas Moniz, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal
Keywords: Cerebral venous thrombosis, Anticoagulants, DOAC, Vitamin K antagonist, Treatment
Received: 16 Aug 2024; Accepted: 29 Aug 2024.
Copyright: © 2024 van de Munckhof, Sánchez van Kammen, Krzywicka, Aaron, Aguiar De Sousa, Antochi, Arauz, Barboza, Conforto, Dentali, Galdames, JI, Jood, Heldner, Hernandez-Perez, Kam, Kleinig, Kristoffersen, Leker, Lemmens, Poli, Yesilot, Wasay, Wu, Arnold, Neto, Middeldorp, Putaala, Tatlisumak, Ferro and Coutinho. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Jonathan M. Coutinho, Department of Neurology, Amsterdam University Medical Center, Amsterdam, Netherlands
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.